Quantification of estrogen receptor alpha and beta expression in sporadic breast cancer. - Wikidata - awgldk - TriplyDB

Quantification of estrogen receptor alpha and beta expression in sporadic breast cancer.

Quantification of estrogen receptor alpha and beta expression in sporadic breast cancer.

http://www.wikidata.org/entity/Q43848239

about

Relationship between intratumoral expression of genes coding for xenobiotic-metabolizing enzymes and benefit from adjuvant tamoxifen in estrogen receptor alpha-positive postmenopausal breast carcinoma Identification of a three-gene expression signature of poor-prognosis breast carcinoma Vandetanib as a potential new treatment for estrogen receptor-negative breast cancers.Arpin downregulation in breast cancer is associated with poor prognosis.Clinical relevance of tumor cells with stem-like properties in pediatric brain tumors.Similar NF-κB gene signatures in TNF-α treated human endothelial cells and breast tumor biopsies.Quantitative real-time RT-PCR and chromogenic in situ hybridization: precise methods to detect HER-2 status in breast carcinoma PIK3R1 underexpression is an independent prognostic marker in breast cancer.Single agent and combination studies of pralatrexate and molecular correlates of sensitivity.Antitumor agent calixarene 0118 targets human galectin-1 as an allosteric inhibitor of carbohydrate binding Protein kinase D1 regulates ERα-positive breast cancer cell growth response to 17β-estradiol and contributes to poor prognosis in patients ATM has a major role in the double-strand break repair pathway dysregulation in sporadic breast carcinomas and is an independent prognostic marker at both mRNA and protein levels.The favourable prognostic value of oestrogen receptor beta immunohistochemical expression in breast cancer.The Possible Impact of Obesity on Androgen, Progesterone and Estrogen Receptors (ERα and ERβ) Gene Expression in Breast Cancer Patients.In-silico identification and functional validation of allele-dependent AR enhancers.Loss of ERbeta expression as a common step in estrogen-dependent tumor progression Identification of new candidate therapeutic target genes in triple-negative breast cancer Estrogen receptor α regulates non-canonical autophagy that provides stress resistance to neuroblastoma and breast cancer cells and involves BAG3 function PIK3CA mutation impact on survival in breast cancer patients and in ERα, PR and ERBB2-based subgroups.Prognostic value of maspin mRNA expression in ER alpha-positive postmenopausal breast carcinomas Predictive factors of sensitivity to elisidepsin, a novel Kahalalide F-derived marine compound Estrogen receptor (ER) beta or p53 attenuates ERalpha-mediated transcriptional activation on the BRCA2 promoter.Prognostic value of a newly identified MALAT1 alternatively spliced transcript in breast cancer.Co-transcriptional R-loops are the main cause of estrogen-induced DNA damage.Sex hormone receptor repertoire in breast cancer.Biopathological Significance of TLR9 Expression in Cancer Cells and Tumor Microenvironment Across Invasive Breast Carcinomas Subtypes.Combination of COX-2 expression and PIK3CA mutation as prognostic and predictive markers for celecoxib treatment in breast cancer.Mutations and polymorphisms of estrogens receptors genes and diseases susceptibility.ERα and ERβ co-expression: An indicator of aggressive tumors and hormonal sensitivity.Unraveling the Role of Huntingtin in Breast Cancer Metastasis.TPD52 represents a survival factor in ERBB2-amplified breast cancer cells.CAG repeat size in Huntingtin alleles is associated with cancer prognosis.Prognostic value of ERBB family mRNA expression in breast carcinomas.Effects of estrogen on collagen synthesis by cultured human osteoblasts depend on the rate of cellular differentiation.Non-competitive steroid inhibition of oestrogen receptor functions.Variations in the mRNA expression of poly(ADP-ribose) polymerases, poly(ADP-ribose) glycohydrolase and ADP-ribosylhydrolase 3 in breast tumors and impact on clinical outcome.Evidence for functional estrogen receptors alpha and beta in human adipose cells: regional specificities and regulation by estrogens.Immunohistochemical expression of estrogen receptor beta in normal and tumoral canine mammary glands.Involvement of the FOXO6 transcriptional factor in breast carcinogenesis.Quantification of PKC family genes in sporadic breast cancer by qRT-PCR: evidence that PKCι/λ overexpression is an independent prognostic factor.

P2860

Q24795015-8FE80D69-D27A-4F09-A82F-CFE7E5882D12 Q24802692-D8FF8C72-CA69-4AF6-B2B6-0E64CAE34E54 Q27853297-06821A08-5363-4913-A19E-8A9153BDD3EF Q30724719-583EA605-48E6-4514-9044-FA034DB6F1BD Q30997872-87F997B3-388F-4C3A-9B20-54224DCDF6A0 Q31022986-A8CE9B8E-FA19-4E45-BF34-F4F38D7321F2 Q33421127-8AC27D7F-7121-40B7-8CCB-906DB49C9155 Q34478129-6121D993-416D-4B26-9640-6309A016352D Q34543815-D827BFDF-428E-454B-BE63-FA218FF456C9 Q34564173-12978512-0484-42E4-A72A-37E8AF77FF6A Q34998421-31F36E6B-EB92-486F-8B4B-9E7E22D52504 Q35198369-E1E57DCB-780F-4847-8FD4-AF4CFCC734AA Q35587582-BEEEAE30-B9FE-43AA-9882-FCC0768DBC9C Q35607776-D45565AA-B82C-45C5-A972-B100E02F181E Q35741562-A3FC3B31-4515-4F39-8B60-D81E719D4B90 Q35888377-82EB217F-F949-457E-A97D-D8AF5E34D3C2 Q36153325-3C9E80CE-C08B-481A-989A-0EA487F42494 Q36293853-04641BAE-9C08-4767-9966-91C120858014 Q36393206-E41C0649-E93E-4AE7-9D72-D2D95610E947 Q36648801-DF5CE0AC-BC67-4CB0-A405-18950E102EEF Q36994186-6092DCAA-F2E8-4BD7-BEA6-DF0E64877AED Q37142529-8F1ACFEA-0783-4022-8C48-1CA066D59069 Q37174025-3545BFBF-E454-4EA6-A61B-E20B423FD3DA Q37270352-7434BBE9-F649-48BC-B2DF-9E2D247FA4A7 Q37353645-52FBEA32-CF05-4550-B43E-5D622088F086 Q37605221-E2C91CE4-D904-443B-AAAE-D527588E90FC Q37709099-C7D3FED4-C6D6-4C7B-9DD8-1D98479F21AE Q38063566-25CE6E31-28AB-4614-8857-08D37B203961 Q38624809-0F1877ED-BED0-48FF-991D-A60B34F743E0 Q38842190-4062F31C-08E4-4F36-84CF-58682C238C05 Q39153926-88140A2D-8CB7-4F0B-A66E-71ED9C6947B5 Q39918359-24120982-C96F-4CB5-A930-A98C33C2B86E Q43461671-324AB098-6FAC-4442-9F99-53D18C5364F0 Q44059983-942D158E-33A2-4949-AD11-1AEF1A6DBDEF Q44124083-C946B00E-8C3F-4692-A0A0-4A3612439DAB Q44542715-D12292F2-94D6-449A-8BE3-56AAB3980106 Q44755136-89792AC8-3B32-4BA5-8F37-F7B30B302E5A Q44888248-5A3FDDDE-2CD1-477A-8849-9C3075AB9F8D Q50350755-9FC9E477-86C4-4E30-AB08-B5B52FB5D1AA Q54314273-3C566225-5E63-4CB9-BC08-D06BD67B7C19

P2860

Quantification of estrogen receptor alpha and beta expression in sporadic breast cancer.

http://www.wikidata.org/entity/Q43848239

description

2001 nî lūn-bûn

@nan

2001年の論文

@ja

2001年学术文章

@wuu

2001年学术文章

@zh

2001年学术文章

@zh-cn

2001年学术文章

@zh-hans

2001年学术文章

@zh-my

2001年学术文章

@zh-sg

2001年學術文章

@yue

2001年學術文章

@zh-hant

name

Quantification of estrogen receptor alpha and beta expression in sporadic breast cancer.

@en

Quantification of estrogen receptor alpha and beta expression in sporadic breast cancer.

@nl

type

label

Quantification of estrogen receptor alpha and beta expression in sporadic breast cancer.

@en

Quantification of estrogen receptor alpha and beta expression in sporadic breast cancer.

@nl

prefLabel

Quantification of estrogen receptor alpha and beta expression in sporadic breast cancer.

@en

Quantification of estrogen receptor alpha and beta expression in sporadic breast cancer.

@nl

P1433

Q43848239-77368E77-16A8-48BA-A30D-ADE7873FD67E

P1476

Q43848239-CD8168A5-3B54-48DF-A85D-C3ED66F0F859

P2093

Q43848239-41164B24-EC9C-4DC0-A71E-B6AF8C5CE4CD

Q43848239-51EF0B34-BF93-47AE-8410-20D71A380B15

Q43848239-88FBB43B-0FE5-450D-B725-86BAAE7B36A4

Q43848239-DFB11E11-DF9A-4050-9CAE-E7BB647B2BD5

Q43848239-E652F754-FA5A-4B36-88DA-BC24CC5CE529

P2860

Q43848239-4254772D-75E3-4DEB-9DEE-CE32DAD1C39F

Q43848239-43B20C35-6880-4E7A-BADE-6758883E607D

Q43848239-81AD60B9-D459-4F77-B71F-49BBDF7782A7

Q43848239-8F15296E-6FC9-4DBE-BC03-ABC2FB174E7C

Q43848239-9B4B4585-DD85-489E-A138-88EB3881CD1E

Q43848239-AB081969-870B-4F77-90B5-EFA7A9AABF6D

Q43848239-B6D3A002-05F9-4767-A3A2-C4C8384D3D47

Q43848239-CDFC18DD-63A9-4490-BF92-D33982E9EBFE

Q43848239-D1B2C604-1BB1-40A7-B6E7-FEE8BCFDD845

Q43848239-F024442C-62D7-45BD-87DF-08E92B9B3636

P2888

Q43848239-75B3878E-0C2F-4F32-833A-46A5165106CD

P304

Q43848239-E970002F-9ABB-43A4-A05C-6EC00E0B120B

P31

Q43848239-4D536FED-601D-4636-867E-C53F0374B4B4

P356

Q43848239-1A306F76-A61E-41E1-8F92-DAE0BC16F2D3

P407

Q43848239-E120CCC1-5C69-4180-9A22-281A5F17B3B3

P433

Q43848239-6025415E-293D-48A3-9A65-9932ED62A747

P478

Q43848239-6EC75833-7422-4A52-9431-042242C35343

P50

Q43848239-187C3688-963F-4743-9309-A576C7C1B094

P577

Q43848239-5BFF5024-4519-4B2E-B5EF-229BA8B0385E

P5875

Q43848239-6C75874F-B12C-4D25-BC96-8707DBB45B39

P6179

Q43848239-4D5D927B-5621-43CD-BB4E-A4595CCAA255

P698

Q43848239-9F1522A4-C08C-49B6-8E37-E2247CEC97AB

P356

P1433

P1476

Quantification of estrogen receptor alpha and beta expression in sporadic breast cancer

@en

P2093

B Parfait

http://www.w3.org/2001/XMLSchema#string

I Girault

http://www.w3.org/2001/XMLSchema#string

I Laurendeau

http://www.w3.org/2001/XMLSchema#string

M Vidaud

http://www.w3.org/2001/XMLSchema#string

R Lidereau

http://www.w3.org/2001/XMLSchema#string

P2860

Positional cloning of ZNF217 and NABC1: genes amplified at 20q13.2 and overexpressed in breast carcinoma

ER beta: identification and characterization of a novel human estrogen receptor

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

Cloning of a novel receptor expressed in rat prostate and ovary

Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years

Nonparametric Estimation from Incomplete Observations

Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites

Estrogen receptor beta is coexpressed with ERalpha and PR and associated with nodal status, grade, and proliferation rate in breast cancer

P2888

P304

8109-8115

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.ONC.1204917

http://www.w3.org/2001/XMLSchema#string

P407

P433

56

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P50

P577

2001-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11576034

http://www.w3.org/2001/XMLSchema#string

P6179

1044769391

http://www.w3.org/2001/XMLSchema#string

P698

11781824

http://www.w3.org/2001/XMLSchema#string